A study led by clinician-scientists and researchers at the National Cancer Centre Singapore (NCCS) has found that the tumor immune microenvironment (TIME) plays a critical role in the progression of ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Quiescence in melanoma is not a rare and static state but a dynamic and reversible condition accessible to most tumor cells, ...

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, ...

The genomic landscape of melanoma not only defines its molecular features but also profoundly influences its immune microenvironment. By analyzing immune cell infiltration patterns across the TCGA ...

Hepatic stellate cells (HSCs) are activated to heal the liver when it has a lesion (such as fibrosis or fatty liver); their function is to protect the liver by producing an extracellular matrix ...

Find all the latest on tumor microenvironment at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.

Notably, miR-153 is secreted by exosomes within the tumor microenvironment, and its release into peritumoral tissues significantly influences tumor cell growth. Exosomal miRNAs show promise for ...

Recent reports show that experts have seen a rise in melanoma cases in Massachusetts, especially among younger women. NewsCenter 5 spoke to Dr. Jeff Yu, a dermatologist at Mass. General Hospital ...

Similarly, in the pooled analysis of median melanoma-specific survival (MSS), combination therapy was associated with longer MSS compared with monotherapy (HR, 0.70; 95% CI, 0.60-0.83) with 6-year MSS ...

The tumor microenvironment significantly influences cancer progression and therapeutic response. Reprogramming of tumor microenvironment has emerged as a strategy to assist conventional cancer ...

CHICAGO — A high-fiber diet intervention produced “promising” response results for patients receiving immune checkpoint inhibitors for melanoma, according to findings presented at ASCO ...